Death receptor-mediated apoptosis and the liver

Journal of Hepatology

Volumn 37, Issue 3, 2002, Pages 400-410

  Yoon, Jung Hwan ^a   Gores, Gregory J ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 3; TNFRSF10A PROTEIN, HUMAN; TNFRSF10B PROTEIN, HUMAN; TNFRSF25 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; DEATH RECEPTOR; NUCLEIC ACID; RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; HUMAN; LIVER DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; ALCOHOL LIVER DISEASE; HEPATITIS; INTRAHEPATIC CHOLESTASIS; LIVER; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WILSON DISEASE;

APOPTOSIS; HUMANS; LIVER DISEASES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SIGNAL TRANSDUCTION; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0036708291     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00209-X     Document Type: Review

References (81)

1. Apoptosis and the liver: Relevance for the hepato-biliary-pancreatic surgeon
2. Death receptors in liver biology and pathobiology
3. Apoptosis and liver disease
4. Death receptors: Signaling and modulation
5. The TNF and TNF receptor superfamilies: Integrating mammalian biology
6. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
7. The CTL's kiss of death
8. Tumor necrosis factor receptor and Fas signaling mechanisms
9. Identification and characterization of a new member of the TNF family that induces apoptosis
10. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
11. The receptor for the cytotoxic ligand TRAIL
12. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway
13. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8
14. Caspase-10 is an initiator caspase in death receptor signaling
15. Inhibition of fas death signals by FLIPs
16. FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis
17. Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling
18. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling
19. Two CD95 (APO-1/Fas) signaling pathways
20. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
21. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
22. The Bcl-2 protein family: Arbiters of cell survival
23. IAP family proteins - Suppressors of apoptosis
24. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
25. Heat shock proteins: Endogenous modulators of apoptotic cell death
26. The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis
27. Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction
28. Lethal effect of the anti-Fas antibody in mice
29. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
30. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
31. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
32. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
33. Fas-mediated cholangiopathy in the murine model of graft versus host disease
34. Expression and antitumor effects of TRAIL in human cholangiocarcinoma
35. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair
36. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand
37. Activated human stellate cells preferentially express death receptor-5 and undergo TRAIL-mediated apoptosis
38. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation
39. Apoptosis: A new mechanism of endothelial and Kupffer cell killing
40. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells
41. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation
42. Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: Implications for the regulation of apoptosis in liver endothelial cells
43. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo?
44. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines
45. Is apoptosis involved in alcoholic hepatitis?
46. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
47. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication
48. Cytochrome P-4502E1: Its physiological and pathological role
49. The central executioners of apoptosis: Caspases or mitochondria?
50. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease
51. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
52. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
53. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor
54. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
55. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
56. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection
57. Fas antigen expression in liver tissues of patients with chronic hepatitis B
58. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver
59. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B
60. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway
61. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins
62. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection
63. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection
64. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha
65. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis
66. Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: Involvement of TNF-alpha receptor 1-independent and -dependent mechanisms
67. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo21
68. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
69. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas
70. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas
71. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury
72. Role of metals in oxygen radical reactions
73. Copper metabolism in primary biliary cirrhosis
74. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis
75. Recognizing death: The phagocytosis of apoptotic cells
76. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo
77. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
78. Corpse clearance defines the meaning of cell death
79. Hepatocyte apoptosis enhances fibrogenic activity of human stellate cells following engulfment of apoptotic bodies - A novel link between two key features of chronic liver disease
80. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway
81. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats